Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Akerna Corp Cl A (KERN)

Akerna Corp Cl A (KERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,246
  • Shares Outstanding, K 10,352
  • Annual Sales, $ 13,650 K
  • Annual Income, $ -79,060 K
  • 60-Month Beta 3.02
  • Price/Sales 0.19
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade KERN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.11
  • Most Recent Earnings $-0.21 on 11/14/23
  • Latest Earnings Date 03/19/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.90
  • Growth Rate Est. (year over year) +111,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2180 +43.85%
on 02/07/24
0.4000 -21.60%
on 01/26/24
-0.0633 (-16.79%)
since 01/08/24
3-Month
0.2180 +43.85%
on 02/07/24
0.5150 -39.11%
on 12/28/23
+0.0537 (+20.66%)
since 11/08/23
52-Week
0.1700 +84.47%
on 09/28/23
1.0900 -71.23%
on 02/16/23
-0.5365 (-63.11%)
since 02/08/23

Most Recent Stories

More News
New Strong Sell Stocks for April 28th

KERN, BRDG and CAC have been added to the Zacks Rank #5 (Strong Sell) List on April 28, 2023.

CAC : 30.51 (-0.61%)
KERN : 6.2720 (+36.94%)
BRDG : 6.65 (+0.45%)
New Strong Sell Stocks for April 26th

KERN, ILLM and ATIP have been added to the Zacks Rank #5 (Strong Sell) List on April 26, 2023.

KERN : 6.2720 (+36.94%)
ATIP : 4.10 (+1.23%)
ILLM : 1.6400 (-1.20%)
Cardiovascular Systems (CSII) Ails From Soft Volume, Macro Woes

Tough competition and consistent net loss continue to pose threats to Cardiovascular Systems (CSII).

HAE : 84.71 (-0.42%)
CSII : 20.00 (+0.15%)
KERN : 6.2720 (+36.94%)
TRSSF : 1.7200 (unch)
Quest Diagnostics (DGX) Updates Its Strategic Focus, LT Growth

Quest Diagnostics (DGX) is building strong platforms to focus on high-growth areas like molecular genomics and oncology.

DGX : 136.76 (+0.04%)
HAE : 84.71 (-0.42%)
KERN : 6.2720 (+36.94%)
TRSSF : 1.7200 (unch)
Here's Why You Should Retain Boston Scientific (BSX) Now

Investors are optimistic about Boston Scientific (BSX), led by impressive value-added acquisitions.

BSX : 73.24 (+6.16%)
HAE : 84.71 (-0.42%)
KERN : 6.2720 (+36.94%)
TRSSF : 1.7200 (unch)
Bruker (BRKR) Receives 1.2 GHz NMR System Orders From the UK

Bruker (BRKR) extends support to the expansion efforts of the UK Science community by providing 1.2 GHz Avance NMR spectrometers.

BRKR : 82.11 (-0.42%)
HAE : 84.71 (-0.42%)
KERN : 6.2720 (+36.94%)
TRSSF : 1.7200 (unch)
Tandem Diabetes (TNDM) Releases Favorable Data on t:slim X2

Tandem Diabetes (TNDM) demonstrated positive results from the clinical trial of advancing its Control-IQ technology to younger age group patients.

TNDM : 34.55 (-1.20%)
HAE : 84.71 (-0.42%)
KERN : 6.2720 (+36.94%)
TRSSF : 1.7200 (unch)
Medtronic's (MDT) Affera Ablation System Gets CE Mark

Medtronic's (MDT) Affera Mapping and Ablation System is intended to treat atrial arrhythmias.

MDT : 80.22 (-1.32%)
HAE : 84.71 (-0.42%)
KERN : 6.2720 (+36.94%)
TRSSF : 1.7200 (unch)
Abbott (ABT) Diabetes Arm Growth Robust Amid Macroeconomic Woes

Abbott (ABT) currently forecasts total organic sales growth, excluding the impact of COVID testing-related sales, to be in the high-single digits in 2023.

ABT : 106.10 (-1.38%)
HAE : 84.71 (-0.42%)
KERN : 6.2720 (+36.94%)
TRSSF : 1.7200 (unch)
NuVasive (NUVA), GMED Merger Aids, Macro Woes Mar Growth

According to NuVasive (NUVA), the combined company is set to have an advanced commercial scale and portfolio of clinically proven solutions.

NUVA : 39.75 (-2.24%)
GMED : 51.27 (+0.43%)
KERN : 6.2720 (+36.94%)
TRSSF : 1.7200 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Akerna Corp. is a regulatory compliance technology company primarily in the cannabis space. The company offer MJ Platform(R) and Leaf Data Systems(R) platforms which provide clients and government entities with a central data management system for tracking regulated cannabis products from seed to product...

See More

Key Turning Points

3rd Resistance Point 0.4091
2nd Resistance Point 0.3645
1st Resistance Point 0.3391
Last Price 6.2720
1st Support Level 0.2691
2nd Support Level 0.2245
3rd Support Level 0.1991

See More

Last Price 6.2720
52-Week High 1.0900
Fibonacci 61.8% 0.7386
Fibonacci 50% 0.6300
Fibonacci 38.2% 0.5214
52-Week Low 0.1700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar